Literature DB >> 1779634

Valproate-induced lethal hyperammonaemic coma in a carrier of ornithine carbamoyltransferase deficiency.

A Tokatli1, T Coşkun, S Cataltepe, I Ozalp.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1779634     DOI： 10.1007/bf01799961

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN： 0141-8955            Impact factor:   4.982


× No keyword cloud information.
  3 in total

1.  Lethal hyperammonaemic coma due to ornithine transcarbamylase deficiency presenting as brain stem encephalitis in a previously asymptomatic ten-year-old boy.

Authors:  T Coskun; I Ozalp; S Mönch; J Kneer
Journal:  J Inherit Metab Dis       Date:  1987       Impact factor: 4.982

2.  Hyperammonemia with valproic acid therapy.

Authors:  D L Coulter; R J Allen
Journal:  J Pediatr       Date:  1981-08       Impact factor: 4.406

3.  Risk of serious illness in heterozygotes for ornithine transcarbamylase deficiency.

Authors:  M L Batshaw; M Msall; A L Beaudet; J Trojak
Journal:  J Pediatr       Date:  1986-02       Impact factor: 4.406
  3 in total
  3 in total

1.  Neurological deterioration in patients with urea cycle disorders under valproate therapy--a cause for concern.

Authors:  A C Sewell; H J Böhles; J Herwig; M Demirkol
Journal:  Eur J Pediatr       Date:  1995-07       Impact factor: 3.183

Review 2.  Neurological implications of urea cycle disorders.

Authors:  A L Gropman; M Summar; J V Leonard
Journal:  J Inherit Metab Dis       Date:  2007-11-23       Impact factor: 4.982

3.  Effect of single oral dose of sodium benzoate on ureagenesis in healthy men and two patients with late onset citrullinaemia.

Authors:  K Kubota; T Ishizaki
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.